Seguir
Chantal M Morel
Chantal M Morel
Afiliación desconocida
Dirección de correo verificada de unibe.ch
Título
Citado por
Citado por
Año
Discovery research: the scientific challenge of finding new antibiotics
DM Livermore, ...
Journal of antimicrobial chemotherapy 66 (9), 1941-1944, 2011
3372011
Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy
S Shillcutt, C Morel, C Goodman, P Coleman, D Bell, CJM Whitty, A Mills
Bulletin of the World Health Organization 86, 101-110, 2008
2962008
Cost effectiveness analysis of strategies to combat malaria in developing countries
CM Morel, JA Lauer, DB Evans
Bmj 331 (7528), 1299, 2005
1862005
International cooperation to improve access to and sustain effectiveness of antimicrobials
C Årdal, K Outterson, SJ Hoffman, A Ghafur, M Sharland, N Ranganathan, ...
The Lancet 387 (10015), 296-307, 2016
1812016
Stoking the antibiotic pipeline
CM Morel, E Mossialos
Bmj 340, 2010
1552010
The urgent need for new antibacterial agents
R Wise, ...
Journal of antimicrobial chemotherapy 66 (9), 1939-1940, 2011
1512011
Policies and incentives for promoting innovation in antibiotic research
E Mossialos, CM Morel, S Edwards, J Berenson, M Gemmill-Toyama, ...
World Health Organization. Regional Office for Europe, 2010
1402010
Disease control priorities in developing countries
JG Breman, A Mills, RW Snow, JA Mulligan, C Lengeler, K Mendis, ...
Washington DC, 2006
1342006
Conquering malaria
JG Breman, A Mills, RW Snow, JA Mulligan, C Lengeler, K Mendis, ...
1152011
Antibiotic research and development: business as usual?
S Harbarth, U Theuretzbacher, J Hackett, Drive-AB Consortium, ...
Journal of Antimicrobial Chemotherapy 70 (6), 1604-1607, 2015
1142015
Mapping global policy discourse on antimicrobial resistance
D Wernli, PS Jørgensen, CM Morel, S Carroll, S Harbarth, N Levrat, ...
BMJ Global Health 2 (2), e000378, 2017
922017
Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus
CM Morel, O Lindahl, S Harbarth, MEA de Kraker, S Edwards, A Hollis
The Journal of antibiotics 73 (7), 421-428, 2020
862020
Human resources estimates and funding for antibiotic stewardship teams are urgently needed
C Pulcini, CM Morel, E Tacconelli, B Beovic, H Goossens, S Harbarth, ...
Clinical Microbiology and Infection 23 (11), 785-787, 2017
852017
Effective antibacterials: at what cost? The economics of antibacterial resistance and its control
AR White, ...
Journal of antimicrobial chemotherapy 66 (9), 1948-1953, 2011
842011
A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa
PG Coleman, C Morel, SAM Shillcutt, C Goodman, AJ Mills
The Intolerable Burden of Malaria II: What's New, What's Needed: Supplement …, 2004
802004
The economics of malaria in pregnancy—a review of the evidence and research priorities
E Worrall, C Morel, S Yeung, J Borghi, J Webster, J Hill, V Wiseman, ...
The Lancet infectious diseases 7 (2), 156-168, 2007
672007
The Millennium Development Goals fail poor children: the case for equity-adjusted measures
DD Reidpath, CM Morel, JW Mecaskey, P Allotey
PLoS medicine 6 (4), e1000062, 2009
572009
Delinking investment in antibiotic research and development from sales revenues: the challenges of transforming a promising idea into reality
K Outterson, U Gopinathan, C Clift, AD So, CM Morel, JA Røttingen
PLoS medicine 13 (6), e1002043, 2016
562016
A one health framework to estimate the cost of antimicrobial resistance
CM Morel, RA Alm, C Årdal, A Bandera, GM Bruno, E Carrara, ...
Antimicrobial Resistance & Infection Control 9, 1-14, 2020
392020
A complexity lens on the COVID-19 pandemic
D Wernli, F Tediosi, K Blanchet, K Lee, C Morel, D Pittet, N Levrat, ...
International journal of health policy and management 11 (11), 2769, 2022
362022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20